- Anaesthesia and Critical Care
- Ear, Nose and Throat
- Infectious Diseases
- Mental Health
- Metabolic and Endocrine
- Musculoskeletal Health
- Neuroprogressive and Dementia
- Oral and Dental
- Primary Care
- Regenerative Medicine
- Reproductive Health and Childbirth
- Trauma and Emergencies
The Cancer Network supports a wide range of clinical studies which are helping to progress cancer care in Scotland and beyond, and all Scottish research ongoing within the network is registered with the National Institute of Health Research (NIHR).
The cancer clinical trial portfolio is very dynamic and is frequently changing as studies open and close to recruitment. Across Scotland, there is a wide range of clinical trials happening in different disease sites. Information on trials happening in the UK can be found on the Be Part of Research platform and the Cancer Research UK website. For specific information on trials happening in Scotland please contact your cancer professional or your local cancer research network.
To highlight the clinical trials happening in Scotland the cancer research network will feature current trials happening during the different cancer awareness months that take place throughout the year.
JUNE: MEN'S HEALTH CANCER AWARENESS MONTH and CERVICAL SCREENING AWARENESS WEEK
June is National Men’s Health Month! This month is all about encouraging men to take care of their bodies by eating well, exercising, and working to prevent disease. The purpose of Men’s Health Month is to heighten the awareness of preventable health problems and encourage early detection and treatment of diseases, including cancer.
On the 14th-21st June 2021 the world also celebrates Men’s Health Week. This is a time to bring awareness to health issues that affect men disproportionately and focuses on getting men to become aware of problems they may have or could develop, and gain the courage to do something about it.
For more information and how you can get involved, visit Men's Health Forum.
Prostate cancer is a type of cancer affecting the prostate gland and only affects men. The prostate is a small gland at the base of the bladder. It is about the size of a walnut but gets bigger as men get older. Symptoms to be aware of are an increased urge to urinate, getting up more frequently in the night to urinate or sometimes difficulty emptying the bladder. It is the most common form of cancer in men and affects over 46,000 men a year.
After studying the effects of aspirin as preventative medicine against heart attacks and strokes, doctors want to find out whether giving patients doses of aspirin could also stop their cancer from returning after treatment. The study is open to anyone and patients will be given different doses of aspirin or a placebo.
This study is recruiting in Aberdeen, Dundee, Edinburgh, Glasgow, Inverness, and various other hospitals in Scotland.
This trial is to find out if having radiotherapy to the lymph nodes in the pelvis as well as the prostate, improves treatment for prostate cancer, and to see if extra boosts of radiotherapy to the prostate is a useful treatment.
It is for men with a medium to high risk of their cancer returning.
This study is recruiting in Aberdeen and Glasgow and soon to open in Inverness.
This is cancer that develops in the testicles. It is fairly rare and only around 2,400 men are diagnosed with testicular cancer each year in the UK. About 50% of those diagnosed are men under 35 years old. It is very important to examine the testicles regularly to check for any changes and go to the doctor if you notice any pain, lump or swelling in the testicles. If caught in time it can be effectively treated and deaths are rare.
It probably won’t be cancer - about 1 lump in 25 is cancerous - but it could be the sign of another condition which if not treated may cause you - and your sex life - serious problems in the future:
For more information on testicular cancer, visit Cancer Research UK.
The aim of the study is to determine if accelerated BEP chemotherapy is superior to standard BEP as a 1st line therapy for patients with intermediate and poor-risk metastatic germ cell tumours. Germ cell tumours (GCTs) account for 98% of all testicular cancers.
This study is currently recruiting patients in Glasgow and Aberdeen and soon to open in Edinburgh.
For more information on this trial, visit Cancer Research UK.
Cervical Screening Awareness Week
14-20 June 2021
Around 3,200 women are diagnosed with cervical cancer in the UK each year. More than half of cases in the UK are diagnosed in women aged 45 or under. Cervical screening is the most effective way of preventing cervical cancer across the UK.
If you are due cervical screening, whether it’s your first or your last test, we’re going to help you understand changes to cervical screening as a result of coronavirus, including what to expect when you go.
This is a Phase II clinical trial of Cediranib and Olaparib maintenance in advanced recurrent Cervical Cancer. This is for patients who have already had chemotherapy treatment which has led to a complete or partial response to the disease or has stabilised the cancer. The trial will also assess levels of toxicity and tolerability to the drug combinations.
COMICE is currently recruiting in Aberdeen and Edinburgh and soon to open in Glasgow.